Exagen Inc. (XGN)
USD 5.52
(-4.83%)
USD 5.52
(-4.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 52.54 Million | 45.56 Million | 48.29 Million | 41.97 Million | 40.38 Million | 32.44 Million |
| Cost of Revenue | 23.09 Million | 24.21 Million | 20.58 Million | 16.55 Million | 18.8 Million | 15.37 Million |
| Gross Profit | 29.45 Million | 21.34 Million | 27.71 Million | 25.41 Million | 21.57 Million | 17.06 Million |
| Operating Expenses | 52.29 Million | 61.89 Million | 51.77 Million | 40.6 Million | 30.87 Million | 21.94 Million |
| Selling, General and Administrative Expenses | 47.42 Million | 52.01 Million | 44.54 Million | 37.03 Million | 28.7 Million | 19.67 Million |
| Research and Development Expenses | 4.86 Million | 9.87 Million | 7.23 Million | 3.56 Million | 2.17 Million | 2.12 Million |
| Other Expenses | - | 5.5 Million | 16 Thousand | 984 Thousand | 510 Thousand | 141 Thousand |
| Cost and Expenses | 75.38 Million | 86.1 Million | 72.36 Million | 57.16 Million | 49.68 Million | 37.32 Million |
| Operating Income | -22.83 Million | -40.54 Million | -24.06 Million | -15.18 Million | -9.29 Million | -4.88 Million |
| Interest Expense | 2.33 Million | 2.44 Million | 2.62 Million | 2.56 Million | 3.49 Million | 2.86 Million |
| Income Tax Expense | 33 Thousand | -282 Thousand | 175 Thousand | -79 Thousand | 25 Thousand | 58 Thousand |
| Earnings before Tax | -23.65 Million | -47.66 Million | -26.67 Million | -16.76 Million | -12.01 Million | -7.95 Million |
| Net Income | -23.68 Million | -47.38 Million | -26.85 Million | -16.68 Million | -12.03 Million | -8.01 Million |
| Earnings Per Share Basic | -1.34 | -2.77 | -1.68 | -1.32 | -0.96 | -127.16 |
| Earnings Per Share Diluted | -1.34 | -2.77 | -1.68 | -1.32 | -0.96 | -127.16 |
| Weighted Average Shares Outstanding | 17.67 Million | 17.08 Million | 15.97 Million | 12.65 Million | 12.56 Million | 63 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 17.67 Million | 17.08 Million | 15.97 Million | 12.65 Million | 12.56 Million | 63 Thousand |
| Gross Margin | 0.56 | 0.47 | 0.57 | 0.61 | 0.53 | 0.53 |
| EBIT Margin | -0.36 | -0.87 | -0.50 | -0.34 | -0.22 | -0.12 |
| Profit Margin | -0.45 | -1.04 | -0.56 | -0.40 | -0.30 | -0.25 |
| EBITDA | -19.15 Million | -43.11 Million | -23.1 Million | -13.65 Million | -7.93 Million | -4.35 Million |
| Earnings Before Tax Margin | -0.43 | -0.89 | -0.50 | -0.36 | -0.23 | -0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 15.06 Million | 14.41 Million | 52.54 Million | 13.76 Million | 13.41 Million | 14.13 Million |
| Cost of Revenue | 6 Million | 5.81 Million | 23.09 Million | 5.62 Million | 5.71 Million | 5.83 Million |
| Gross Profit | 9.05 Million | 8.59 Million | 29.45 Million | 8.14 Million | 7.7 Million | 8.3 Million |
| Operating Expenses | 11.64 Million | 11.6 Million | 52.29 Million | 13.29 Million | 12.77 Million | 13.21 Million |
| Selling, General and Administrative Expenses | 10.46 Million | 10.54 Million | - | 12.21 Million | 11.37 Million | 11.95 Million |
| Research and Development Expenses | 1.17 Million | 1.05 Million | - | 1.07 Million | 1.4 Million | 1.26 Million |
| Other Expenses | - | - | - | -687 Thousand | 211 Thousand | 476 Thousand |
| Cost and Expenses | 17.65 Million | 17.41 Million | 75.38 Million | 18.91 Million | 18.48 Million | 19.05 Million |
| Operating Income | -2.58 Million | -3 Million | -22.83 Million | -5.14 Million | -5.06 Million | -4.91 Million |
| Interest Expense | 560 Thousand | 549 Thousand | 2.33 Million | 566 Thousand | -557 Thousand | 574 Thousand |
| Income Tax Expense | - | 414.72 Thousand | 33 Thousand | 6000.00 | -605 Thousand | 547 Thousand |
| Earnings before Tax | -2.96 Million | -3.36 Million | -23.65 Million | -5.56 Million | -5.41 Million | -5.01 Million |
| Net Income | -2.96 Million | -3.36 Million | -23.68 Million | -5.57 Million | -5.41 Million | -5.01 Million |
| Earnings Per Share Basic | -0.16 | -0.19 | - | -0.31 | -0.31 | -0.28 |
| Earnings Per Share Diluted | -0.16 | -0.19 | - | -0.31 | -0.31 | -0.28 |
| Weighted Average Shares Outstanding | 18.17 Million | 17.94 Million | 17.67 Million | 17.83 Million | 17.69 Million | 17.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.17 Million | 17.94 Million | 17.67 Million | 17.83 Million | 17.69 Million | 17.65 Million |
| Gross Margin | 0.60 | 0.60 | 0.56 | 0.59 | 0.57 | 0.59 |
| EBIT Margin | -0.14 | -0.18 | - | -0.34 | -0.38 | -0.31 |
| Profit Margin | -0.20 | -0.23 | -0.45 | -0.40 | -0.40 | -0.35 |
| EBITDA | -2.15 Million | -2.54 Million | - | -4.64 Million | -5.06 Million | -4.43 Million |
| Earnings Before Tax Margin | -0.17 | -0.21 | -0.43 | -0.37 | -0.38 | -0.35 |
RKKE
600287
CNND
BIOX
7062
7115